Delivery Order SPE2DR25D3005-SPE2DR26FP7UL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Xeomin 100 unit vials valued at $7,360.25. This firm fixed-price delivery order is scheduled for completion by December 17, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures without any set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $93,868.32 firm fixed-price delivery order for 200-unit vials of Xeomin on October 17, 2025, with an ultimate completion date of November 7, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $23,553.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials. The contract, issued on November 17, 2025, has an ultimate completion date of December 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xeomin 200 Unit Vials, with a ceiling value of $23,553.20 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,766.46 for 100-unit vials of Xeomin on December 3, 2025, with completion scheduled for December 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8,832.40 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials. This non-competitive delivery order, issued on November 24, 2025, operates under a firm fixed price structure with an ultimate completion date of December 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued against AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $7,542.99 firm fixed price delivery order by the Defense Logistics Agency's Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 21, 2025. The award covers the supply of Xeomin 100 Unit vials and represents a competitively awarded, non-set-aside contract. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $49,460.88 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Xeomin 200 unit vials, with performance completion scheduled for December 30, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is located at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Xeomin 100 unit vials. The contract utilizes firm fixed pricing and is scheduled for completion by November 7, 2025. This is an unset-aside, competitively awarded delivery order, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xeomin 100 unit vials valued at $6,704.88 with a firm fixed price structure. The order is scheduled for completion by August 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7ULDelivery Order
The Defense Logistics Agency awarded a $1,766.49 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Xeomin 200 unit vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant role in the federal medical procurement supply chain. The company has demonstrated consistent capability in meeting competitive federal procurement requirements through its extensive portfolio of pharmaceutical deliveries with the Defense Logistics Agency and Medical Supply Chain, covering diverse therapeutic domains from specialty medications to vaccines and medical devices. This award reflects the company's ongoing role as a critical vendor for military and veteran healthcare systems under the flexible IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/4/25 |